机构:[1]Sarcoma Unit, Royal Marsden NHS Foundation Trust, London, UK[2]The Institute of Cancer Research, London, UK[3]Orthopaedic Research Institute, West China Hospital, Sichuan University, 610041 Sichuan, China四川大学华西医院
第一作者机构:[1]Sarcoma Unit, Royal Marsden NHS Foundation Trust, London, UK
通讯作者:
推荐引用方式(GB/T 7714):
Napolitano Andrea,Huang Paul H,Jones Robin L,et al.Immune checkpoint inhibition in sarcomas: time to be histology-specific?[J].The Lancet. Oncology.2022,23(9):1111-1112.doi:10.1016/S1470-2045(22)00500-9.
APA:
Napolitano Andrea,Huang Paul H,Jones Robin L&Tu Chongqi.(2022).Immune checkpoint inhibition in sarcomas: time to be histology-specific?.The Lancet. Oncology,23,(9)
MLA:
Napolitano Andrea,et al."Immune checkpoint inhibition in sarcomas: time to be histology-specific?".The Lancet. Oncology 23..9(2022):1111-1112